FDA Budget Enhances Safety Programs, But Relies On Theoretical User Fees
Executive Summary
FDA proposes to increase its medical product safety spending by $100.8 million in the fiscal 2011 budget submitted to Congress Feb. 1
You may also be interested in...
Pediatric Labeling Extrapolation From Adults To Be Addressed In FDA Manual
FDA's Office of Pediatric Therapeutics expects to develop by 2012 a manual to guide agency staff on the use of extrapolation when assessing pediatric products and their development programs
Pediatric Labeling Extrapolation From Adults To Be Addressed In FDA Manual
FDA's Office of Pediatric Therapeutics expects to develop by 2012 a manual to guide agency staff on the use of extrapolation when assessing pediatric products and their development programs
FDA Biosimilars Program Gets Seed Money In Administration's FY '11 Budget
FDA plans to spend $5.7 million in fiscal 2011 to develop drug review standards and make other preparations for an approval pathway for follow-on biologics